Pharos MT Limited (production of finished medicinal product, primary and secondary packaging, batch control, batch release)
UkraineAll medications by this manufacturer
-
Nilotinib-vista
Form: capsules, hard
Active substance Dosage nilotinib 50 mg ATC: L01EA03
-
Nilotinib-vista
Form: capsules, hard
Active substance Dosage nilotinib 150 mg ATC: L01EA03
-
Nilotinib-vista
Form: capsules, hard
Active substance Dosage nilotinib 200 mg ATC: L01EA03